Jane Wasman

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: SELLAS Life Sciences Group Inc., 3 years.

3 years · Since 2023
3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
May 15, 2026 Rigel Pharmaceuticals Inc. Grant or award +5,750 — —
Jan 7, 2026 SELLAS Life Sciences Group Inc. Grant or award +50,000 — —
May 30, 2025 SELLAS Life Sciences Group Inc. Open-market purchase +20,000 $1.69 $33,800
May 23, 2025 Rigel Pharmaceuticals Inc. Grant or award +2,500 — —
Jan 10, 2025 SELLAS Life Sciences Group Inc. Grant or award +12,500 — —
May 25, 2024 Rigel Pharmaceuticals Inc. Grant or award +25,000 — —
Jan 22, 2024 SELLAS Life Sciences Group Inc. Grant or award +6,000 — —
May 26, 2023 Rigel Pharmaceuticals Inc. Grant or award +25,000 — —
Feb 2, 2023 SELLAS Life Sciences Group Inc. Grant or award +2,500 — —

Questions about Jane Wasman

What boards is Jane Wasman on?

Jane Wasman sits on the boards of Rigel Pharmaceuticals Inc. and SELLAS Life Sciences Group Inc.

How long has Jane Wasman served on boards?

Our records show at least 7 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.